Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer

NCT04428203 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Recurrent
Prostate Cancer
Prostate Adenocarcinoma

Interventions

DRUG: Epidiolex Oral Liquid Product
DRUG: Epidiolex Oral Liquid Product
DRUG: Epidiolex Oral Liquid Product

Sponsor

Zin W Myint